EFFICIENCY AND SAFETY OF NEURAMINIDASE INHIBITOR OSELTAMIVIR FOR CHILDREN

QR Code

EFFICIENCY AND SAFETY OF NEURAMINIDASE INHIBITOR OSELTAMIVIR FOR CHILDREN

Every year 3 to 5 million people suffer from flu. Children are most susceptible to flu. At the moment, the main methods of flu prophylaxis and treatment are flu vaccination and antivirus medications. Of the tested anti virus medications, 3 groups are most interesting and interferon inductors, м 2=ch...

Full description

Saved in:

Bibliographic Details
Main Author:	A.S. Darmanyan
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2007-10-01
Series:	Педиатрическая фармакология
Online Access:	https://www.pedpharma.ru/jour/article/view/727
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

OSELTAMIVIR IN FLU TREATMENT AND PREVENTION AMONG CHILDREN
by: T.V. Kulichenko, et al.
Published: (2007-12-01)

OPPORTUNITIES FOR APPLICATION OF THE NEURAMINIDASE INHIBITORS IN TREATMENT AND PREVENTION OF THE FLU
by: Yu.B. Belan, et al.
Published: (2007-08-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
by: A.B. Ivanyuk, et al.
Published: (2008-01-01)

OSELTAMIVIR APPLICATION AMONG HIV-INFECTED CHILDREN, SUFFERING FROM THE FLU
by: Yu.A. Fomin, et al.
Published: (2007-11-01)

Neuraminidase Inhibitors: Development and Validation of a Procedure for <i>In Vitro</i> Determination of the Inhibitory Effect
by: N. M. Faustova, et al.
Published: (2023-03-01)

The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews.
by: Barbara Michiels, et al.
Published: (2013-01-01)

OSELTAMIVIR IN PEDIATRIC PRACTICES (WORLD'S APPLICATION EXPERIENCE)
by: A.S. Kolbin, et al.
Published: (2008-11-01)

Anti-neuraminidase immunity in the combat against influenza
by: Xiaojian Zhang, et al.
Published: (2024-12-01)

Clinical efficacy and Safety of Baloxavir Marboxil compared with Oseltamivir against influenza virus in children: A systematic review and meta-analysis
by: Ling Zhu, et al.
Published: (2025-01-01)

Clinical efficacy and Safety of Baloxavir Marboxil compared with Oseltamivir against influenza virus in children: A systematic review and meta-analysis.
by: Ling Zhu, et al.
Published: (2025-01-01)

Managing Seasonal Influenza: Oseltamivir Treatment Policy in Indonesia?
by: Herman Kosasih, et al.
Published: (2014-01-01)

Managing Seasonal Influenza: Oseltamivir Treatment Policy in Indonesia?
by: Herman Kosasih, et al.
Published: (2014-01-01)

Managing Seasonal Influenza: Oseltamivir Treatment Policy in Indonesia?
by: Herman Kosasih, et al.
Published: (2014-01-01)

Effect of Oseltamivir Use on Follow-Up Stroke Mortality
by: Pei-Hua Chuang, et al.
Published: (2025-05-01)

Use of neuraminidase inhibitors for rapid containment of influenza: a systematic review and meta-analysis of individual and household transmission studies.
by: George N Okoli, et al.
Published: (2014-01-01)

Discovery of Novel Natural Inhibitors of H5N1 Neuraminidase Using Integrated Molecular Modeling and ADMET Prediction
by: Afaf Zekri, et al.
Published: (2025-06-01)

Evaluation of the efficacy of triazavirin versus oseltamivir in management of COVID-19
by: Sara Samir Mohamed Elmenshawy, et al.
Published: (2024-12-01)

Recombinant Escherichia coli Strain with Enhanced Production of Vibrio cholerae Neuraminidase
by: E. V. Monakhova, et al.
Published: (2019-07-01)

Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial
by: A. V. Averyanov, et al.
Published: (2020-05-01)

Evaluation of the Efficacy of Riamilovir and Oseltamivir Combination on the Experimental Model of Mice Influenza Infection
by: I. N. Falynskova, et al.
Published: (2020-05-01)

Clinical efficacy of baloxavir marboxil versus oseltamivir in kidney transplant recipients with influenza
by: Jiali Jiang, et al.
Published: (2025-07-01)

NEURAMINIDASE INHIBITORS — NEW OPPORTUNITIES IN THE FLU TREATMENT IN RECENT YEARS, WHEN SOMEONE SAYS FLU, DOCTORS RECALL SUCH A THING, AS «THE VACCINATION AGAINST THE FLU».
by: M.D. Bakradze, et al.
Published: (2007-04-01)

Influenza B virus neuraminidase: a potential target for next-generation vaccines?
by: Thi Hoai Thu Do, et al.
Published: (2024-12-01)

A 15-year study of neuraminidase mutations and the increasing of S247N mutation in Spain
by: Iván Sanz-Muñoz, et al.
Published: (2025-08-01)

Receptor Binding Properties of Neuraminidase for influenza A virus: An Overview of Recent Research Advances
by: Lian Liu, et al.
Published: (2023-12-01)

The Flu Epidemic in Russia in the 2013 - 2014 Season: Etiology, Antigenic Properties of Hemagglutinin and Neuraminidase Activity
by: T. G. Lobova, et al.
Published: (2015-04-01)

Functionalized selenium nanoparticles enhance the anti-EV71 activity of oseltamivir in human astrocytoma cell model
by: Jiayu Zhong, et al.
Published: (2019-12-01)

Effect of D-Mannose on Gene Expression of Neuraminidase Produced from Different Clinical Isolates of Pseudomonas aeruginosa
by: Shehab et al.
Published: (2019-06-01)

Multivalent COBRA Hemagglutinin and Neuraminidase Influenza Vaccines Adjuvanted with TLR9 Agonist CpG 1018
by: Pedro L. Sanchez, et al.
Published: (2025-06-01)

EFFICIENCY AND SAFETY OF VACCINATION AGAINST CHICKENPOX IN CHILDREN
by: A.G. Rumyantsev
Published: (2007-10-01)

Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection
by: Xuhui Liu, et al.
Published: (2013-01-01)

<i>In silico</i> modeling of N294S mutation effect on the interaction of influenza virus N8 neuraminidase with zanamivir
by: E. A. Rukhlova, et al.
Published: (2025-01-01)

Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01)

RATIONAL THERAPY OF CHILDREN'S CROUP
by: M.D. Bakradze, et al.
Published: (2007-09-01)

INCREASED ANTI-INFLUENZA EFFICACY OF OSELTAMIVIR (TAMIFLU<sup>®</sup>) AND UMIFENOVIR (ARBIDOL<sup>®</sup>) BY COMBINED USE WITH KAGOCEL<sup>®</sup>
by: A. F. Popov, et al.
Published: (2020-05-01)

RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017-12-01)

PRACTICAL APPLICATION OF MODERN METHODS OF INPATIENT STREPTOCOCCAL INFECTION DIAGNOSTICS
by: A. S. Darmanyan
Published: (2013-09-01)

PHYLOGENETIC ANALYSIS OF NEURAMINIDASE GENE OF INFLUENZA A(H3N2) VIRUSES ISOLATED IN UKRAINE IN 2013–2014 SEASON
by: С. В. Бабій, et al.
Published: (2015-06-01)

Neuraminidase 1 Exacerbated Glycolytic Dysregulation and Cardiotoxicity by Destabilizing SIRT1 through Interactions with NRF2 and HIF1α
by: Ting Gao, et al.
Published: (2025-07-01)

EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN
by: A. A. Ruleva, et al.
Published: (2013-01-01)